Travere Therapeutics Inc (TVTX)

Sep 10, 2026

Travere Therapeutics (NASDAQ: TVTX) director plans 2026 stock sale - Stock Titan

Sep 10, 2026

Sep 10, 2026

TVTX: FILSPARI's momentum and pipeline progress position the business for sustained growth - TradingView

Sep 10, 2026

Sep 10, 2026

Travere Therapeutics at Cantor conference: filspari drives growth By Investing.com - Investing.com Canada

Sep 10, 2026

Sep 10, 2026

Travere Therapeutics stock hits 52-week high at 68.25 USD - Investing.com

Sep 10, 2026

Sep 09, 2026

Travere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease - Stocktwits

Sep 09, 2026

Sep 08, 2026

Travere Therapeutics' Outlook Brightens As Turnaround Looms - Investor's Business Daily

Sep 08, 2026

Sep 08, 2026

FDA issues Untitled Letter to Travere Therapeutics over visual aid for kidney disease drug Filspari - Medical Marketing and Media

Sep 08, 2026

Sep 05, 2026

TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits

Sep 05, 2026

Sep 05, 2026

TVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside - Stocktwits

Sep 05, 2026

Sep 04, 2026

Seong Chi: Excited to Join Travere Therapeutics as Director, Scientific Engagement and Professional Societies - Oncodaily

Sep 04, 2026

Sep 04, 2026

Biotech Stocks At 52-Week HighsATTO, HALO, IKT, TVTX, ATRC - RTTNews

Sep 04, 2026

Sep 03, 2026

Travere Therapeutics CFO Christopher R. Cline Executes 642-Share Sale for Tax Withholding on RSU Vesting - Kalkine Media

Sep 03, 2026

Sep 03, 2026

Travere Therapeutics stock hits 52-week high at 67.97 USD By Investing.com - Investing.com Australia

Sep 03, 2026

Sep 03, 2026

Travere Therapeutics stock hits 52-week high at 67.97 USD - Investing.com

Sep 03, 2026

Sep 03, 2026

Responsive Playbooks and the TVTX Inflection - Stock Traders Daily

Sep 03, 2026

Sep 02, 2026

Travere (NASDAQ: TVTX) CFO executes tax-withholding stock sale - Stock Titan

Sep 02, 2026

Aug 22, 2026

TVTX | Travere Therapeutics, Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative

Aug 22, 2026

Aug 21, 2026

Travere Therapeutics stock hits 52-week high at 66.35 USD By Investing.com - Investing.com South Africa

Aug 21, 2026

Aug 21, 2026

Travere Therapeutics (TVTX) Is Up 6.1% After FILSPARI Beats FSGS Launch Expectations - Sahm

Aug 21, 2026

Aug 21, 2026

Travere Therapeutics stock hits 52-week high at 66.35 USD - Investing.com

Aug 21, 2026

Aug 19, 2026

Travere Therapeutics (TVTX) director sells 10K shares under 10b5-1 plan - Stock Titan

Aug 19, 2026

Aug 19, 2026

Travere Therapeutics: Valuation Suggests A Buy (NASDAQ:TVTX) - Seeking Alpha

Aug 19, 2026

Aug 19, 2026

US High Growth Tech Stocks To Watch In August 2026 - Sahm

Aug 19, 2026

Aug 18, 2026

Travere Therapeutics (NASDAQ: TVTX) director plans 5,000-share sale tied to stock options - Stock Titan

Aug 18, 2026

Aug 18, 2026

Travere Therapeutics Sees FILSPARI FSGS Launch Top Expectations, Expands Renal Pipeline - Yahoo Finance

Aug 18, 2026

Aug 17, 2026

Travere Therapeutics, Inc. SEC Filing (Aug 17, 2026) - Stock Titan

Aug 17, 2026

Aug 17, 2026

Travere Therapeutics (TVTX) Advances 3.12% to $64.08, Approaching Key Resistance at $67.28Dark Pool Sentiment - vinanet.vn

Aug 17, 2026

Aug 17, 2026

TVTX Stock On Track To Hit Near 20-Year Highs After Filspari Becomes The Only Approved FSGS Treatment - Stocktwits

Aug 17, 2026

Aug 17, 2026

Travere Therapeutics (TVTX) Q2 2026 Earnings Call Transcript - AOL.com

Aug 17, 2026

Aug 16, 2026

S&CO Inc. Makes New Investment in Travere Therapeutics, Inc. $TVTX - MarketBeat

Aug 16, 2026

Aug 14, 2026

Travere Therapeutics (TVTX) sees Armistice Capital report 1.67% ownership in 13G/A - Stock Titan

Aug 14, 2026

Aug 14, 2026

Bank of America Corp DE Trims Position in Travere Therapeutics, Inc. $TVTX - MarketBeat

Aug 14, 2026

Aug 13, 2026

Travere Therapeutics (TVTX) Is Up 7.5% After Strong Q2 Revenue But Wider Net LossHas The Bull Case Changed? - webull.com

Aug 13, 2026

Aug 13, 2026

(TVTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Aug 13, 2026

Aug 13, 2026

Travere Therapeutics, Inc. Stock 12‑Month Price Target Raised to $74.62, Implies 20% Upside - TradingView

Aug 13, 2026

Aug 12, 2026

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule - TradingView

Aug 12, 2026

Aug 12, 2026

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Aug 12, 2026

Aug 12, 2026

Bank of America Corp (TVTX) discloses 5.8% beneficial stake in Travere Therapeutics - Stock Titan

Aug 12, 2026

Aug 12, 2026

What is HC Wainwright's Estimate for TVTX Q3 Earnings? - marketbeat.com

Aug 12, 2026

Aug 12, 2026

Travere Therapeutics, Inc. $TVTX Shares Bought by Quantinno Capital Management LP - MarketBeat

Aug 12, 2026

Aug 10, 2026

TVTX Maintained by Evercore ISI Group -- Price Target Raised to $78 - GuruFocus

Aug 10, 2026

Aug 10, 2026

Wall Street Analysts Are Neutral on Top Healthcare Picks - The Globe and Mail

Aug 10, 2026

Aug 10, 2026

California State Teachers Retirement System Increases Stock Holdings in Travere Therapeutics, Inc. $TVTX - MarketBeat

Aug 10, 2026

Aug 10, 2026

Assenagon Asset Management S.A. Boosts Stock Holdings in Travere Therapeutics, Inc. $TVTX - MarketBeat

Aug 10, 2026

Aug 09, 2026

Hennion & Walsh Asset Management Inc. Raises Holdings in Travere Therapeutics, Inc. $TVTX - MarketBeat

Aug 09, 2026

Aug 08, 2026

Travere Therapeutics Reports First Quarter 2026 Financial Results - The National Law Review

Aug 08, 2026

Aug 08, 2026

Travere Therapeutics, Inc. (TVTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 08, 2026